On Nov 8, 2021 QuantuMDx Group closed a Venture – Series Unknown round and raised £15,000,000 from Vita Spring IVD Fund, featuring lead investors Vita […]
Series A – Beacon Biosignals
On Nov 8, 2021 Beacon Biosignals closed a Series A round and raised $27,000,000 from Andrew Beck, Casdin Capital, General Catalyst, featuring lead investors General […]
Post-IPO Equity – RedHill Biopharma
On Nov 8, 2021 RedHill Biopharma closed a Post-IPO Equity round and raised $10,000,000 from Kukbo, featuring lead investors Kukbo. About the company: RedHill Biopharma […]
Series A – Marengo Therapeutics
On Nov 8, 2021 Marengo Therapeutics closed a Series A round and raised $80,000,000 from Apple Tree Partners, featuring lead investors Apple Tree Partners. About […]
Venture Round – QuantuMDx Group
On Nov 8, 2021 QuantuMDx Group closed a Venture – Series Unknown round and raised £15,000,000 from Vita Spring IVD Fund, featuring lead investors Vita […]
Series B – Platelet BioGenesis
On Nov 4, 2021 Platelet BioGenesis closed a Series B round and raised $75,500,000 from K2 HealthVentures, Oxford Finance LLC, Qiming Venture Partners, SymBiosis LLC, […]
Series A – Cellenkos
On Nov 4, 2021 Cellenkos closed a Series A round and raised $15,000,000 from BVCF, featuring lead investors BVCF. About the company: Cellenkos is located […]
Series B – Molecular Assemblies
On Nov 4, 2021 Molecular Assemblies closed a Series B round and raised $10,000,000 from SynBio Innovation Accelerator, featuring lead investors SynBio Innovation Accelerator. About […]
Venture Round – B-Secur
On Nov 4, 2021 B-Secur closed a Venture – Series Unknown round and raised £8,800,000 from Co-FundNI, First Capital Ventures, Kernel Capital, Wharton Asset Management […]
Angel Round – Hale Therapeutics
On Nov 4, 2021 Hale Therapeutics closed a Angel round and raised $200,000 from Robert Corrato, Robert Keith, featuring lead investors Robert Corrato, Robert Keith. […]
